"Durable Responses with Vemurafenib plus Rituximab in Hairy-Cell Leukemia."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Of 30 patients with relapsed or refractory hairy-cell leukemia, 87% experienced complete responses. Click to show full abstract

Of 30 patients with relapsed or refractory hairy-cell leukemia, 87% experienced complete responses.

Keywords: responses vemurafenib; durable responses; cell leukemia; hairy cell

Journal Title: Cancer discovery
Year Published: 2021

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended